Aurora Cannabis announces proposed public offering on the Toronto stock exchange: ACB

EDMONTON, Alta., November 10, 2020 (GLOBE NEWSWIRE) – Aurora Cannabis Inc. (the “Company” or “Aurora”) (NYSE | TSX: ACB), the Canadian company defining the future of cannabinoids around the world, announced today ‘hui that it will file a preliminary prospectus supplement (the “provisional supplement”) to its simplified base shelf prospectus dated October 28, 2020 (the “base shelf prospectus”) relating to a proposed overnight public sale offer. the day (the “Offering”) of units of the Company (the “Units”) at a price of US $ 7.50 per unit, for aggregate gross proceeds to the Company of approximately US $ 125 million.

Each Unit will consist of one common share of the Company (one “Common Share”) and one-half of a common share purchase warrant of the Company (each full Common Share purchase warrant, one “warrant”). subscription”). Each warrant may be exercised to acquire one common share of the Company (a “share with warrant”) for a period of 40 months following the closing date of the offering at an exercise price of US $ 9.00. per share with warrant, subject to adjustment in certain events. .

The final terms of the Offer must be determined at the time of pricing. There can be no guarantee as to whether or when the investment may be made, or as to the actual size or terms of the investment. Closing of the offering will be subject to market and other customary conditions, including the approvals of the Toronto Stock Exchange and the New York Stock Exchange.

In addition, the Company intends to grant the Underwriters a 30 day option to purchase up to an additional 15% of the Units offered under the proposed offering on the same terms and conditions. This option may be exercised by the underwriters for additional units, common shares, warrants or any combination of such securities.

The Company expects to use the net proceeds of the Offering, if any, to fund growth opportunities, working capital and other general corporate purposes.

BMO Capital Markets and ATB Capital Markets act as bookkeepers for the Offering.

The Preliminary Supplement will be filed with the securities commissions or similar securities regulatory authorities in each of the provinces of Canada, except Quebec, and with the United States Securities and Exchange Commission (the “SEC ) As part of the company’s registration statement on Form F -10 (the “Registration Statement”) under the United States / Canada Multi-Jurisdictional Disclosure System. The preliminary supplement, the base shelf prospectus and the registration statement contain important detailed information about the company and the proposed offering. Prospective investors should read the Preliminary Supplement, the Base shelf Prospectus and the Registration Statement and other documents that the Company has filed to obtain more complete information about the Company and this Offer before making an investment decision.

Copies of the Preliminary Supplement, after filing thereof, and the Base Shelf Prospectus will be available on SEDAR at www.sedar.com and copies of the Preliminary Supplement and the Registration Statement will be available on EDGAR at www. sec.gov. Copies of the Preliminary Supplement, after filing thereof, the Base Shelf Prospectus and the Registration Statement may also be obtained from BMO Capital Markets by contacting BMO Capital Markets, Brampton Distribution Center C / O The Data Group of Companies, 9195 Torbram Road, Brampton, Ontario, L6S 6H2 or by phone at (905) 791-3151 ext 431 or by email at [email protected] or BMO Capital Markets Corp., Attn .: Equity Syndicate Department, 3 Times Square, 25th Floor, New York, NY 10036 (Attn: Equity Syndicate), or by phone at (800) 414-3627 or by email at [email protected]. Copies of these documents may also be obtained from ATB Capital Markets Inc., Attn: Gail O’Connor, 410-585 8th Ave SW, Calgary, Alberta, T2P 1G1, (403) 539-8629 or by email to atbcm_dealflow @ atb. com.

No securities regulatory authority has approved or disapproved of the contents of this press release. This press release is for informational purposes only and does not constitute an offer to sell or the solicitation of an offer to buy, nor any sale of such securities in any state or jurisdiction where such offer, solicitation or sale would be illegal. . prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Aurora

Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Based in Edmonton, Alberta, Aurora is a global cannabis pioneer dedicated to helping people improve their lives. The company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler and Reliva CBD. Providing customers with innovative and high-quality cannabis products, Aurora’s brands continue to establish themselves as industry leaders in the medicine, performance, wellness and leisure markets, wherever they are launched. For more information, please visit our website at www.auroramj.com.

Aurora’s common shares trade on the TSX and NYSE under the symbol “ACB” and are included in the S & P / TSX Composite Index.

Further information

Forward-looking statements

This press release contains statements containing certain “forward-looking information” within the meaning of applicable securities laws (“forward-looking statements“). Forward-looking statements are often characterized by words such as” plan “,” continue “,” expect “,” plan “,” intend “,” believe “,” anticipate “,” estimate ” , “may,” “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will occur.” Forward-looking statements made in this press release include statements regarding: the timing, prices, and completion of the Offer and the intended use of proceeds from the Offer. These forward-looking statements are only predictions. Various assumptions have been used in drawing conclusions or making projections contained in forward-looking statements throughout this press release.statements are based on the opinions, estimates and assumptions of management in light of management’s experience and its perception of historical trends s, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to keep selling, administrative and other overhead costs in line with current expectations, the ability to earn high margin revenues in the Canadian consumer market, the current and future regulatory environment, and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management considers relevant and reasonable in the circumstances could cause events, results, level of activity, performance, actual outlook, opportunities or achievements differ significantly from these. projected in forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the expected benefits associated with the acquisition of Reliva, the completion of Aurora’s business transformation plan, the conditions general trade and economic conditions, changes in laws and regulations, demand for products, changes in the prices of required commodities, competition, effects and responses to the COVID-19 pandemic and other risks, uncertainties and factors defined under the heading ” risk “of the Company’s Annual Information Form dated September 24, 2020 (the”AIF) And filed with Canadian securities regulatory authorities, available on the Company’s Issuer Profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov. The Company cautions that the list of risks, uncertainties and other factors described in the Annual Information Form is not exhaustive and that other factors could also adversely affect its results. Readers are urged to carefully consider the risks, uncertainties and assumptions when evaluating forward-looking statements, and are cautioned not to place undue reliance on such information. The Company has no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise, except as expressly required. by applicable securities laws.